Across India, tens of millions carry a silent infection that most will never know they have — until the damage is already done. In a country that bears nearly a eighth of the world's Hepatitis B burden, fewer than one in thirty infected people have been diagnosed, and treatment reaches almost no one. Mission Defeat Hepatitis, a partnership between pharmaceutical company Cipla and the Indian liver disease association INASL, is now scaling its screening effort to reach 2.5 lakh people through thousands of camps nationwide, wagering that visibility and access can begin to close a gap that has lon
India Scales Hepatitis B Screening to 2.5 Lakh Tests Amid Low Diagnosis Rates
Millions of Indians living with undiagnosed Hepatitis B face risk of severe liver complications including cirrhosis and cancer due to lack of early detection and treatment access.